Professional Documents
Culture Documents
The Use of Cryosurgery in Treatment of The Gingival Leukoplakia: Report of A Case Series
The Use of Cryosurgery in Treatment of The Gingival Leukoplakia: Report of A Case Series
Case Report
The Use of Cryosurgery in Treatment of the Gingival Leukoplakia: Report of a Case Series
Adriana Spinola Ribeiro, Mauro Henrique Nogueira Guimarães de Abreu, Tarcília Aparecida da Silva,
Ricardo Alves Mesquita
Abstract
Background: Oral leukoplakia is preferentially treated by conventional surgery, but other
treatments may also be considered. Conventional surgery cannot be used for high-risk surgical
patients, have high-time of work and for large or multiples lesions is necessary two or more
excisions with high-risk to prove scar. On the other hand, cryosurgery did not present these
disadvantages. Aims & Objectives: To report of a case series of gingival leukoplakia treated with
cryosurgery. Materials and Methods: Incisional biopsy was performed. The procedure was
performed with Cry-Ac® using the spray technique for two consecutive freeze cycles of 10
seconds, under local anesthesia. The performance of the cryosurgery was evaluated according
to: 1) postoperative pain, 2) edema, 3) bleeding, 4) secondary infection, 5) clinical healing, 6) loss
tissue, 7) scarring, and 8) recurrence of the lesion. Results: The mean age of patients was 57.6
years and there were more women (5 patients). The microscopic evaluation demonstrated
hyperkeratosis in 3 cases, hyperkeratosis with mild epithelial dysplasia in 2 cases and
hyperkeratosis with moderate epithelial dysplasia in 1 case. No bleeding, no loss of tissue, no
scarring, and no infection could be observed following the treatment. Also, pain was not noticed
by patients. Three patients reported discrete edema within 24 hours after treatment. All treated
gingival sites were clinically healing of leukoplakia and recurrence was not observed.
Conclusions: In this light, when leukoplakia involves the gingiva, cryosurgery should be
considered the treatment of choice. In addition, cryosurgery can potentially be used in the
treatment of other gingival conditions.
Adriana Spinola Ribeiro, Mauro Henrique Nogueira Guimarães de Abreu, Tarcília Aparecida da Silva,
Ricardo Alves Mesquita. The Use of Cryosurgery in Treatment of the Gingival Leukoplakia: Report of a Case
Series. International Journal of Oral & Maxillofacial Pathology; 2012:3(1):28-33. ©International Journal of
Oral and Maxillofacial Pathology. Published by Publishing Division, Celesta Software Private Limited. All
Rights Reserved.
©2012 International Journal of Oral and Maxillofacial Pathology. Published by Publishing Division, Celesta Software Private Limited. All Rights Reserved
29 Ribeiro AS. et al ISSN 2231 - 2250
2,4,5,7
Discussion ablasion. Conventional surgery is more
OL has an annual malignant transformation frequently used, but may cause scars and a
20,21
rate of 0.1% to 17.0%. The degree of loss of tissue and there is a high time of
dysplasia is regarded as the most important work in relation to the cryosurgery.
indicator of potential progression. OL Moreover, recurrence has been reported in
23,30
presenting low to moderate malignant risk 10% to 35% of the cases. Results of
may either be completely removed or not, treatment with cryosurgery have been
and the decision should consider factors varied. A 32% recurrence rate of OL cases
such as gender, location, size and, in the treated by cryosurgery has been reported
case of smokers, the patient’s dedication to when considering follow-up periods of 3 to
2 10
quitting smoking. OL’s located on the floor 46 months . Other investigators have
of the mouth, soft palate, and tongue are obtained recurrence rates of 0% in 3
15 8
considered lesions of high-risk for malignant months and 6 months and 3% in 12
6
transformation, while, in other areas, such months. However, in other studies, the
as the gingiva, these are considered to recurrence rates from treatment with
4
represent a low risk of malignancy. Prior cryosurgery have proven to be variable
7,9,11,30
reports have described a predominance in within a period of up to five years. No
the buccal mucosa and the lower alveolar recurrence of GL in the cases studied herein
22-24
mucosa as the main locations of OL. could be observed within an 24-month
However, other studies have defended that follow-up period.
25-28
the gingiva is the most frequent location.
The frequent involvement of the gingival Our results demonstrate that 100% of the
area has mostly been described in studies GL cases treated with cryosurgery
carried out in the USA, with OL occurring in presented a total clinical healing. Healed
22,24
23.7% to 41.8% of these cases. gingival tissue could be observed with a
Therefore, the GL is a frequent condition in normal clinical appearance without
clinical practices and its appropriate leukoplakia. Loss of tissue, postoperative
management is necessary. The present pain, hemorrhage, infection, or scarring did
study includes a series of six cases of GL not occur in any of the cases. The present
which were successfully treated with study results are in accordance with the
cryosurgery. The choice of treatment of GL majority of the studies reviewed concerning
with cryosurgery was justified due to 1) the the treatment of OL with cryosurgery in
29 6-11,30
aesthetic factor; 2) the degree of dysplasia ; locations other than the oral mucosa.
29,30 29,30
3) no smoking ; and 4) gender. Furthermore, the uneventful healing in the
present study was corroborated by previous
OL is commonly treated by conventional results in which cryosurgery was used to
7,30
surgery, electrocautery, cryosurgery, or laser treat GL.
Table 1: Clinical and microscopic findings of six patients with gingival leukoplakia treated with
cryosurgery.
31 Ribeiro AS. et al ISSN 2231 - 2250
Figure 1: Clinical aspects of gingival Clinically normal gingiva after the treatment
leukoplakia (1A, 1C, 1E, 1G, 1I, 1K). with cryosurgery (1B, 1D, 1F, 1H, 1J, 1L).
ISSN 2231 – 2250 Cryosurgery in Treatment of the Leukoplakia..... 32
cryotherapy for oral leukoplakia. Head 22. Waldron CA, Shafer WG. Leukoplakia
Neck 2009;31:983–8. revisited: A clinicopathologic study of
12. Ameerally PJ, Colver GB. Cutaneous 3256 oral leukoplakias. Cancer
cryotherapy in maxillofacial surgery. J 1975;36:1386-92.
Oral Maxillofac Surg 2007;65:1785-92. 23. Silverman S, Gorsky M, Lozada F. Oral
13. Farah CS, Savage NW. Cryotherapy for leukoplakia and malignant
treatment of oral lesions. Austr Dent J transformation. A follow-up study of 257
2006;51:2-5. patients. Cancer 1984;53:563-8.
14. Malmström M, Leikomaa H. Experiences 24. Bouquot JE, Gorlin RJ. Leukoplakia,
with cryotherapy in the treatment of oral lichen planus, and other oral keratoses
lesions. Proc Finn Dent Soc in 23,616 white Americans over the age
1980;76:117-23. of 35 years. Oral Surg Oral Med Oral
15. Tal H, Cohen MA, Lemmer J. Clinical Pathol 1986;61:373-81.
and histological changes following 25. Saito T, Sugiura C, Hirai A, Totsuka Y,
cryotherapy in a case of widespread oral Shindoh M, Kohgo T, et al. High
leukoplakia. Int J Oral Surg 1982;11:64- malignant transformation rate of wide
8. spread multiple oral leukoplakias. Oral
16. Tal H, Landsberg J, Kozlovsky A. Dis 1999;5:15-9.
Cryosurgical depigmentation of the 26. Ishii J, Fujita K, Komori T. Clinical
gingiva. J Clin Periodontol 1987;14:614- assessment of laser monotherapy for
7. squamous cell carcinoma of the mobile
17. Yeh CJ. Cryosurgical treatment of tongue. J Clin Laser Med Surg
melanin-pigmented gingiva. Oral Surg 2002;20:57-61.
Oral Med Oral Pathol Oral Radiol Endod 27. Scheifele C, Reichart PA, Dietrich T.
1998;86:660-3. Low prevalence of oral leukoplakia in
18. Yeh CJ. Treatment of verrucous representative sample of the US
hyperplasia and verrucous carcinoma by population. Oral Oncol 2003;39:619-25.
shave excision and simple cryosurgery. 28. van der Waal I. Potentially malignant
Int J Oral Maxillofac Surg 2003;32:280– disorders of the oral and oropharyngeal
3. mucosa; terminology, classification and
19. Caraceni A, Cherny N, Fainsinger R, present concepts of management. Oral
Kaasa S, Poulain P, Radbruch L, et al. Oncol 2009;45:317-23.
Pain measurement tools and methods in 29. Napier SS, Speight PM. Natural history
clinical research in palliative care: of potentially malignant oral lesions and
recommendations of an expert working conditions: an overview of the literature.
group of the European Association of J Oral Pathol Med 2008;37:1-10.
Palliative Care. J Pain Symp Manage 30. Kuflik EG. Cryosurgery updated. J Am
2002;23:239–55. Acad Dermatol 1994;31:925-46.
20. Saito T, Sugiura C, Hirai A, Notani K,
Totsuka Y, Shindoh M, et al. Corresponding Author
Development of squamous cell Dr.Ricardo Alves Mesquita,
carcinoma from pre-existent oral Universidade Federal de Minas Gerais
leukoplakia: with respect to treatment Faculdade de Odontologia,
Departamento de Clínica,
modality. Int J Oral Maxillofac Surg Patologia e Cirurgia Odontológicas
2001;30:49-53. Av.: Antônio Carlos, 6627, Sala 3202-D
21. Lodi G, Porter S. Management of Pampulha, 31.270-901,
potentially malignant disorders: evidence Belo Horizonte, MG – Brasil.
and critique. J Oral Pathol Med Voice: +55 31 34092499 or +55 31
2008;37:63-9. 34092479
Fax: +55 31 34092430
E-mail: ramesquita@ufmg.br